Ace Susung New Technology Fund 3, Dongyu Investment Co., Ltd and Nau Growth Capital PEF fund managed by Nau IB Capital, Investment Arm signed a stock definitive agreement to acquire 3.2% stake in Pharma Research Products Co., Ltd (KOSDAQ:A214450) from Jung, Sang-Soo for KRW 16 billion on March 12, 2018. As per terms, a total of 0.3 million shares will be acquired at KRW 53,046 per share. The consideration will be paid on closing. The deal is expected to close on March 21, 2018. Ace Susung New Technology Fund 3, Dongyu Investment Co., Ltd and Nau Growth Capital PEF fund managed by Nau IB Capital, Investment Arm completed the acquisition of 3.2% stake in Pharma Research Products Co., Ltd (KOSDAQ:A214450) from Jung, Sang-Soo on March 26, 2018.